BPC-157 & TB-500 & GHK-Cu Blend Research Peptide: A Triple‑Action Tool for Angiogenesis, ECM & Tissue Repair Studies
If your research investigates the complex interplay between angiogenesis, extracellular matrix (ECM) remodelling, and tissue repair, the BPC-157 & TB-500 & GHK-Cu Blend research peptide — often referred to as the “GLOW Stack” in research circles — offers a sophisticated, multi‑pathway experimental platform. This formulation combines three well‑characterised regenerative peptides—BPC‑157 (a stable gastric pentadecapeptide), TB‑500 (a synthetic fragment of Thymosin Beta‑4), and GHK‑Cu (a naturally occurring copper‑binding tripeptide)—each acting through complementary mechanisms to promote angiogenesis, integrin‑mediated ECM remodelling, fibroblast activation, and collagen synthesis. By targeting distinct yet convergent pathways, this blend allows researchers to model the synergistic interplay between these regenerative signalling systems, providing deeper insight into the regulatory circuits that govern tissue repair and recovery.
At Chinese Grey Peptides, we supply high‑purity BPC-157 & TB-500 & GHK-Cu Blend research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into angiogenesis, ECM biology, and tissue regeneration begin with uncompromising quality.
What Is the BPC-157 & TB-500 & GHK-Cu Blend and How Does It Work?
To fully appreciate the research potential of the BPC‑157 & TB‑500 & GHK‑Cu Blend research peptide, it is essential to understand the distinct yet complementary mechanisms of its three components. The blend is typically supplied as a lyophilised powder in a single vial — a format that collapses three reconstitution events into one, preserving experimental efficiency and reproducibility.
BPC‑157: The Pro‑Angiogenic Tissue Protector
BPC‑157 (Body Protection Compound‑157) is a synthetic 15‑amino‑acid pentadecapeptide (sequence GEPPPGKPADDAGLV) derived from a naturally occurring protein fragment found in human gastric juice. It is notable for its remarkable physicochemical stability and its pleiotropic tissue‑protective effects. Research demonstrates that BPC‑157 promotes angiogenesis through the activation of the VEGFR2‑Akt‑eNOS signalling pathway, increasing the expression and internalisation of VEGFR2 in vascular endothelial cells. It has been shown to accelerate blood flow recovery and increase vessel number in models of hind limb ischemia. BPC‑157 also enhances growth hormone receptor expression, reduces inflammatory cytokines, and supports soft tissue repair across tendons, muscles, ligaments, and nerves.
TB‑500: The Actin‑Binding Cellular Migrator
TB‑500 is a synthetic peptide corresponding to the active site (residues 17‑23: Ac‑LKKTETQ) of the naturally occurring protein Thymosin Beta‑4 (Tβ4). As a fragment, it retains the actin‑binding and cell‑migration‑promoting properties of the full‑length protein. TB‑500 binds to monomeric G‑actin, regulating actin dynamics and promoting cellular migration to sites of injury. It also supports endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, and collagen deposition, while reducing inflammation. This peptide is often associated with broader systemic recovery mechanisms, supporting tissue regeneration across multiple tissue types.
GHK‑Cu: The Copper‑Binding Gene Modulator
GHK‑Cu (glycyl‑L‑histidyl‑L‑lysine‑copper complex) is a naturally occurring copper‑binding tripeptide first isolated from human plasma in 1973. It functions as both a signal and a carrier peptide, supporting extracellular matrix remodelling. GHK‑Cu has a profound influence on gene expression — modulating roughly 31% of profiled human genes in cultured fibroblasts — and upregulates genes involved in antioxidant defence, tissue repair, and anti‑inflammatory pathways. It stimulates collagen I and III, elastin, and decorin synthesis, upregulates VEGF and basic FGF transcripts, and exerts potent anti‑inflammatory and antioxidant effects.
Mechanism of Synergy: Complementary Pathways in Tissue Repair
The scientific rationale for combining BPC‑157, TB‑500, and GHK‑Cu lies in their convergent yet distinct mechanisms. When conceptualised as a blended research framework, these peptides invite investigation into how their complementary properties might interact:
-
BPC‑157 provides the angiogenic and tissue‑protective signal, promoting blood vessel formation and vascular stability.
-
TB‑500 enhances systemic cellular motility, driving the migration of repair cells to the wound site and organising the repair environment.
-
GHK‑Cu provides the structural support, modulating gene expression to promote collagen synthesis and ECM remodelling.
This triple‑pathway activation enables researchers to model the complex, multi‑stage process of tissue repair — from initial vascular response and cellular recruitment to matrix remodelling and functional recovery. In research settings, the blend targets complementary biological pathways: BPC‑157 builds new blood supply and activates growth factor programmes; TB‑500 mobilises cells to the injury site; and GHK‑Cu drives collagen synthesis and structural regeneration.
Key Research Applications for the BPC-157 & TB-500 & GHK-Cu Blend
The BPC‑157 & TB‑500 & GHK‑Cu Blend research peptide is a versatile tool with applications spanning several domains of biomedical research.
1. Wound Healing & Tissue Repair Research
As a blend of wound‑healing peptides, this formulation is a valuable tool for studying tissue regeneration. Research applications include:
-
Acute Wound Models: Investigating the blend’s ability to accelerate wound closure and promote tissue regeneration.
-
Tendon and Ligament Repair: BPC‑157 has shown accelerated healing rates in tendon injuries; TB‑500 promotes muscle fibre regeneration.
-
Musculoskeletal Repair: Studying the potential benefits of the blend in tendon, ligament, and muscle repair models.
-
Combination Studies: Comparing the blend’s effects against single‑compound controls to elucidate synergistic mechanisms.
2. Angiogenesis & Vascular Research
As a blend that promotes angiogenesis through multiple mechanisms, this formulation is a valuable tool for studying blood vessel formation and vascular integrity. Research applications include:
-
Endothelial Cell Function: Studying how the blend influences endothelial cell proliferation, migration, and tube formation.
-
Vascular Remodelling: Exploring the peptide’s potential role in promoting angiogenesis and revascularisation of injured tissues.
-
Ischaemic Models: Investigating the blend’s ability to improve blood flow to areas with limited circulation.
3. Extracellular Matrix & Fibroblast Research
The blend promotes integrin‑mediated ECM remodelling and fibroblast activation, making it a valuable tool for studying connective tissue biology. Research applications include:
-
Collagen Synthesis: Investigating the synergistic effects of GHK‑Cu and BPC‑157 on collagen production.
-
Fibroblast Activation: Studying how the blend influences fibroblast migration, proliferation, and ECM deposition.
-
ECM Remodelling: Exploring integrin‑mediated extracellular matrix remodelling and structural regeneration.
4. Inflammatory & Immune Modulation Research
BPC‑157, TB‑500, and GHK‑Cu are studied for their ability to influence inflammatory pathways and support tissue repair. Research applications include:
-
Inflammatory Signalling: Investigating how the blend modulates inflammatory cascades and reduces excessive inflammation.
-
Cytokine Modulation: Studying the regulation of cytokine and chemokine pathways.
-
Reduced Swelling and Pain: Exploring the blend’s potential to reduce inflammation and support recovery.
5. Skin & Connective Tissue Research
GHK‑Cu’s role in collagen and elastin synthesis positions this blend as a valuable tool for dermatological research. Research applications include:
-
Skin Rejuvenation: Investigating how GHK‑Cu improves skin density, thickness, wrinkles, and pigmentation.
-
Connective Tissue Remodelling: Studying the synergistic effects of the blend on collagen and elastin production.
-
Wound Healing: Exploring the potential of the blend to accelerate wound closure and support tissue regeneration.
Chemical & Physical Specifications for BPC-157 & TB-500 & GHK-Cu Blend
Accurate characterisation of the BPC-157 & TB-500 & GHK-Cu Blend research peptide is essential for reproducible experimental design.
| Parameter | Specification |
|---|---|
| Common Names | BPC‑157 & TB‑500 & GHK‑Cu Blend, “GLOW Stack” |
| Components | BPC‑157, TB‑500, GHK‑Cu |
| BPC‑157 Sequence | Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val (GEPPPGKPADDAGLV) |
| TB‑500 Sequence | Ac‑Leu‑Lys‑Lys‑Thr‑Glu‑Thr‑Gln (Ac‑LKKTETQ) |
| GHK‑Cu Sequence | Gly‑His‑Lys‑Cu²⁺ |
| BPC‑157 Molecular Weight | ~1499.7 g/mol |
| TB‑500 Molecular Weight | ~889.01 g/mol |
| GHK‑Cu Molecular Weight | ~401.91 g/mol |
| Total Mass | 70 mg (50 mg GHK‑Cu, 10 mg TB‑500, 10 mg BPC‑157) |
| Purity (Each Component) | ≥99% (HPLC verified) |
| Appearance | White to off‑white lyophilised powder |
| Solubility | Soluble in sterile water and sterile PBS (pH 5‑7) |
| Characteristic Indicator | Deep‑blue tint upon reconstitution (from GHK‑Cu chelate) |
| Storage (Lyophilised) | –20°C, sealed, protected from light; stable for up to 2 years |
| Storage (Reconstituted) | 2‑8°C for short‑term use; single‑use aliquots at –20°C for up to 3 months |
Note: The total mass represents the combined peptide weight of the blend, as provided in the product specification. The blend is supplied in a single lyophilised vial. GHK‑Cu imparts a characteristic deep‑blue tint to the lyophilised powder upon reconstitution. This product is intended strictly for in‑vitro and laboratory research use only (RUO). Not for human or animal use.
Reconstitution & Handling Protocol for the BPC-157 & TB-500 & GHK-Cu Blend
Proper reconstitution of the BPC-157 & TB-500 & GHK-Cu Blend research peptide is critical for maintaining the structural integrity and biological activity of all three peptides. Each component has a distinct stability profile, so careful handling is essential.
Step 1 – Preparation
-
Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.
-
Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.
Step 2 – Vial Sanitisation
-
Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.
Step 3 – Reconstitution
-
Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 1.5‑2 mL of diluent per 70 mg blend, yielding a total peptide concentration of approximately 35‑47 mg/mL.
-
Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.
-
Gently swirl the vial until the solution is clear and fully dissolved. GHK‑Cu will impart a deep‑blue tint to the solution — this is normal. Do not shake vigorously, as shaking can cause denaturation.
Step 4 – Aliquoting & Storage
-
Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.
-
Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.
-
Once thawed, store at 2‑8°C and use within a short period.
Concentration Reference Table for BPC-157 & TB-500 & GHK-Cu Blend
| Blend Mass | Diluent Volume | Total Final Concentration |
|---|---|---|
| 70 mg | 1.0 mL | 70 mg/mL |
| 70 mg | 1.4 mL | 50 mg/mL |
| 70 mg | 2.0 mL | 35 mg/mL |
Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is 50 mg GHK‑Cu, 10 mg TB‑500, and 10 mg BPC‑157 per 70 mg vial.
Storage & Stability Guidelines for BPC-157 & TB-500 & GHK-Cu Blend
| Storage Condition | Shelf Life | Notes |
|---|---|---|
| Lyophilised at –20°C, unopened | 2 years | Use desiccant, protect from light |
| Lyophilised at 2‑8°C, unopened | 6‑12 months | –20°C storage is strongly preferred for long‑term stability |
| Reconstituted at 2‑8°C | Short‑term use | Use within days to weeks |
| Reconstituted aliquots at –20°C | Up to 3 months | Single freeze only; discard after thawing |
Why Choose Chinese Grey Peptides for the BPC-157 & TB-500 & GHK-Cu Blend ?
As an authentic licensed peptide supplier based in the USA, we supply the BPC-157 & TB-500 & GHK-Cu Blend research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).
-
Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for each component, every batch.
-
Identity Confirmation: Mass spectrometry (ESI‑MS or MALDI‑TOF) confirms the identity of each component.
-
Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.
-
Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.
-
USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).
Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.
FAQ: BPC-157 & TB-500 & GHK-Cu Blend Research Peptide
What is the BPC-157 & TB-500 & GHK-Cu Blend research peptide?
It is a research‑grade formulation combining BPC‑157 (a stable gastric pentadecapeptide), TB‑500 (a synthetic fragment of Thymosin Beta‑4), and GHK‑Cu (a naturally occurring copper‑binding tripeptide). It is used as a triple‑pathway tool to study angiogenesis, ECM remodelling, fibroblast activation, and tissue repair.
How does each component work?
BPC‑157 promotes angiogenesis via VEGFR2‑Akt‑eNOS activation. TB‑500 binds actin monomers to regulate actin filament dynamics and enhance cell migration. GHK‑Cu modulates gene expression, stimulates collagen synthesis, and exerts antioxidant and anti‑inflammatory effects.
What is the proposed synergy between these three peptides?
BPC‑157 provides the angiogenic and tissue‑protective signal; TB‑500 enhances cellular motility; and GHK‑Cu provides the structural support for ECM remodelling. Together, they model the complex, multi‑stage process of tissue repair.
What is the typical composition of the blend?
The blend is typically supplied as 50 mg GHK‑Cu, 10 mg TB‑500, and 10 mg BPC‑157 in a single lyophilised vial (70 mg total).
Why does the reconstituted blend appear blue?
The deep‑blue tint upon reconstitution comes from the GHK‑Cu chelate and is a normal visual indicator of the blend.
What purity does your BPC-157 & TB-500 & GHK-Cu Blend meet?
Each component is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.
How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.
How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.
Is this peptide blend legal to purchase in the USA for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: These peptides are not FDA‑approved for human use.
Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.
Final Thoughts
From its innovative design as a synergistic blend of three well‑characterised regenerative peptides to its well‑documented role in modelling the complex interplay between angiogenesis, ECM remodelling, and tissue repair, the BPC-157 & TB-500 & GHK-Cu Blend research peptide provides a uniquely versatile platform for advanced biomedical research.
Its ability to promote angiogenesis via VEGFR2‑Akt‑eNOS signalling, enhance cellular motility through actin modulation, and influence the expression of thousands of genes through copper‑mediated signalling—supported by peer‑reviewed research and authoritative analytical characterisation—makes it a valuable addition to any laboratory investigating angiogenesis, ECM biology, wound healing, or tissue regeneration. By choosing high‑purity, lab‑verified BPC-157 & TB-500 & GHK-Cu Blend research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.
Ready to advance your research with the BPC-157 & TB-500 & GHK-Cu Blend research peptide? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the USA, UK, or Europe.BPC-157 & TB-500 & GHK-Cu Blend
BPC-157 & TB-500 & GHK-Cu Blend
BPC-157 & TB-500 & GHK-Cu Blend




Reviews
There are no reviews yet.